Senate Caucus on International Narcotics Control Hearing: “Cannabidiol: Barriers to Research and Potential Medical Benefits” Wednesday, June 24, 2015
Thank you for allowing me to step in to make a brief statement.
I’m heartened by the attention this issue is receiving. CBD has shown tremendous promise in reducing the devastating effects of epilepsy. It offers hope to thousands of children nationwide who each day endure terrifying, uncontrollable seizures. It offers hope as well to parents who must endure the repeated agony of helplessly watching as their children suffer seizure after seizure after seizure.
Ask Paige Figi, whose eight-year-old daughter suffered as many as 300 grand mal seizures per week before starting treatment with CBD, and she will tell you that CBD is a lifesaver. After Charlotte started taking CBD, her seizures dropped dramatically. She now suffers, on average, less than three seizures per month and is able to engage in normal childhood activities.
Now, I understand the desire for caution. We’re Congress. We act slowly. But we must remember that these are people’s lives we’re dealing with. These are people for whom a five- or ten-year delay is not an inconvenience, but a potential death sentence.